Metrorrhagia after intravitreal injection of bevacizumab-Reference-Cited by-同舟云学术

Metrorrhagia after intravitreal injection of bevacizumab

Published:2007-07-23 Issue:8 Volume:85 Page:915-916
ISSN:1395-3907
Container-title:Acta Ophthalmologica Scandinavica
language:en
Short-container-title:

Author:

Rodrigues Eduardo B.,Shiroma Helio,Meyer Carsten H.,Maia Maurício,Farah Michel E.

Publisher

Wiley

Subject

Ophthalmology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0420.2007.00968.x/fullpdf

Reference6 articles.

1. BC Cancer Agency 2006 Cancer management guidelines. Management guidelines of bevacizumab-related side effects http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/default.htm

2. Csaky K 2007 Safety surveillance in the anti-VEGF era: myths and misconceptions http://www.osnsupersite.com/view.asp?rid=19510

3. Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events;Hurwitz;Semin Oncol,2006

4. Antiangiogenesis therapy for endometriosis;Nap;J Clin Endocrinol Metab,2004

5. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion;Pai;Am J Ophthalmol,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pregnancy-associated Retinal Diseases and Their Management;Survey of Ophthalmology;2013-03

2. A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS;Retina;2011-09

3. Toxicological considerations for intravitreal drugs;Expert Opinion on Drug Metabolism & Toxicology;2011-06

4. Descending doses of intravitreal bevacizumab for the regression of diabetic neovascularization;Acta Ophthalmologica;2011-04-18

5. Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease;Survey of Ophthalmology;2011-03